tiprankstipranks
Trending News
More News >
Nektar Therapeutics (NKTR)
NASDAQ:NKTR

Nektar Therapeutics (NKTR) Revenue

Compare
1,421 Followers

Nektar Therapeutics Revenue

Nektar Therapeutics had a revenue of 10.46M in the quarter ending Mar 31, 2025, with -64.15%. This bring the company's revenue in the last twelve months to 87.25M, Increased -11.36%. In the fiscal year ending Dec 31, 2024, Nektar Therapeutics had annual revenue of 98.43M with 9.22% growth.
Revenue (ttm)
87.25M
Revenue Growth
-3.24%
P/S Ratio
3.67
Revenue/Employee
$1,613,557
Employees
61
Market Cap
$361.29M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
98.43M8.30M+9.22%
Dec 31, 2023
90.12M-1.93M-2.10%
Dec 31, 2022
92.06M-9.85M-9.67%
Dec 31, 2021
101.91M-51.01M-33.36%
Dec 31, 2020
152.91M38.30M+33.41%
Dec 31, 2019
114.62M-1.08B-90.40%
Dec 31, 2018
1.19B885.61M+287.81%
Dec 31, 2017
307.71M142.28M+86.00%
Dec 31, 2016
165.44M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis